Search Press releases Keywords From To 9 Jan 2025 UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform Read More 7 Jan 2025 Transparency notification Wellington Read More 16 Dec 2024 Findings from minzasolmin proof-of-concept ORCHESTRA study shape next steps in UCB Parkinson’s research program Read More 29 Nov 2024 UCB Focuses on New Launch and Completes Divestment of Mature Product Business in China Read More 27 Nov 2024 UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual Meeting Read More 20 Nov 2024 UCB receives U.S. FDA approval for BIMZELX[®] (bimekizumab-bkzx) as the first IL-17A and IL-17F inhibitor for adults with moderate to severe hidradenitis suppurativa Read More Pagination First page Previous page Previous … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Page 17 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
